Instituto de Oncologia de Sorocaba/Onco Clinicas Especializadas

Sorocaba 18030-005

0 studies enrolling now · 2 studies all time

What they study most

Receptors, Fibroblast Growth Factor, Urothelial Cancer

Studies at this site

• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed